RSD-2 mediates RDE-4-independent antiviral silencing in Caenorhabditis elegans by Zhang, Rui
Louisiana State University
LSU Digital Commons
LSU Master's Theses Graduate School
2012
RSD-2 mediates RDE-4-independent antiviral
silencing in Caenorhabditis elegans
Rui Zhang
Louisiana State University and Agricultural and Mechanical College, zhang20120809@gmail.com
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_theses
This Thesis is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU
Master's Theses by an authorized graduate school editor of LSU Digital Commons. For more information, please contact gradetd@lsu.edu.
Recommended Citation
Zhang, Rui, "RSD-2 mediates RDE-4-independent antiviral silencing in Caenorhabditis elegans" (2012). LSU Master's Theses. 1145.
https://digitalcommons.lsu.edu/gradschool_theses/1145
RSD-2 MEDIATES RDE-4-INDEPENDENT ANTIVIRAL SILENCING IN 
CAENORHABDITIS ELEGANS 
 
 
A Thesis 
Submitted to the Graduate Faculty of the 
Louisiana State University and 
Agricultural and Mechanical College 
in partial fulfillment of the 
requirements for the degree of 
Master of Science 
 
in 
The Department of Biological Sciences 
 
 
 
 
 
 
by 
Rui Zhang 
B.S., North China Coal Medical University, 2003 
M.S., Huazhong University of Science and Technology, 2008 
December 2012
 ii 
 
ACKNOWLEDGMENTS 
          My greatest thanks go to my major professor, Dr. Rui Lu, for his great help for me to join 
in his lab, for his devotement on mentoring and guidance on the way in my research and life, and 
for his dedication in writing lots of supporting materials for my graduate study, international 
meetings’ attendance and membership application, student travel and research awards 
application, career application, and for his contribution on improving my scientific writing. I 
especially thank him for teaching me how to do research.   
          I would like to thank Dr. Craig Hart, Dr. Samithamby Jeyaseelan, and Dr. Huangen Ding 
for their devotedness on being my committee members, providing beneficial suggestions, 
evaluations and stimulating questions in my study.  
           I would like to thank Dr. Shisheng Li’s support, valuable advices and recommendation 
letters for my study.  
          I would like to thank Dr. Jacqueline Stephens for her useful advices in my study. 
          I would like to thank Dr. Dominique G. Homberger, Dr. Christopher Austin, Dr. Sue G. 
Bartlette, Dr. William T. Doerrler, Dr. John C. Larkin, Dr. Patrica Moroney, Dr. George M. 
Strain, Dr. Arthur Penn, Dr. Masami Yoshimura, Dr. James E. Miller, Dr. Shisheng Li, Dr. 
Samithamby Jeyaseelan, etc., for their teaching or holding biological sciences curricula and 
seminars.  
 iii 
 
          I would like to thank Dr. Binghao Luo for his instructive advices and thought-provoking 
questions during our joint-lab meeting.  
          I would like to thank Dr. E. William Wischusen and Ms. Ann D Jolissaint for their 
guidance in teaching Introductory Biology Laboratory for undergraduates.  
          I would like to thank Xiaoping Yi, Xunyang Guo, Jeffrey Wang, Gwin Kelly, Yunbing 
Ma, Yanling Meng, Ying Guan, Zhe Rui, Yu-Hsin Hsueh, and my friends at LSU.  
          I would like to thank Dr. Fengchao Jiang, Dr. Ge Meng, Dr. Wanlong Ding, and Dr. Yong 
Li for their support in my graduate study application. 
          My special thanks go to my parents Lihua Yang and Yuling Zhang for their never-ending 
support. 
 
 
 
 
 
 
 
 
 
 
 iv 
 
TABLE OF CONTENTS 
ACKNOWLEDGMENTS .............................................................................................................. ii 
LIST OF FIGURES ....................................................................................................................... vi 
ABSTRACT ................................................................................................................................. viii 
CHAPTER ONE: INTRODUCTION ............................................................................................. 1 
1.1 C. elegans as a Model Organism .......................................................................................... 1 
1.2 RNA Interference .................................................................................................................. 4 
1.3 RNAi Directed Viral Immunity (RDVI) ............................................................................... 6 
1.4 Flock House Virus (FHV)..................................................................................................... 6 
1.5 Orsay Virus ........................................................................................................................... 7 
1.6 The rsd-2 Gene ..................................................................................................................... 8 
CHAPTER TWO: MATERIALS AND METHODS ................................................................... 12 
2.1 C. elegans Genetics and Culture ......................................................................................... 12 
2.2 Transgenic Construct and Transgenic Worms .................................................................... 12 
2.3 Orsay Virus Infections ........................................................................................................ 13 
2.4 RNAi Experiments .............................................................................................................. 13 
2.5 RNA Preparation and Northern Blot Analysis ................................................................... 13 
2.6 RSD-2 Functional Rescue Experiment ............................................................................... 14 
2.7 Imaging Microscopy ........................................................................................................... 14 
CHAPTER THREE: STRATEGIES TO STUDY RDVI IN C. ELEGANS AND RESULTS ..... 15 
3.1 Initiate FHV Replication in C. elegans ............................................................................... 15 
3.2 Identify Genes Required for Antiviral RNAi in C. elegans by Feeding RNAi .................. 16 
3.3 Rsd-2 Is Required for Antiviral RNAi in C. elegans .......................................................... 19 
3.3.1 Rsd-2 Is Required for RNAi Targeting FHV in C. elegans ............................................. 19 
3.3.2 Rsd-2 Is Required for RDVI Targeting Orsay Virus in C. elegans ................................. 20 
3.3.3 Wild Type rsd-2 Can Rescue RDVI in rsd-2 Knockout Mutants .................................... 21 
 v 
 
3.3.4 Rsd-2 Is Not Required for viRNA Biogenesis ................................................................. 22 
3.4 Delineate an rsd-2-dependent Genetic Pathway That Contributes to RDVI in C. elegans 23 
3.4.1 Both FHV and Orsay Virus Replication Were Enhanced in rsd-2;rde-4 Double Mutants 
Compared to Either rsd-2 or rde-4 Single Mutants .................................................................. 25 
3.4.2 Both FHV and Orsay Virus Replication Were Enhanced in rsd-2;drh-1 Double Mutants 
Compared to Corresponding Single Mutants ............................................................................ 27 
3.4.3 Both FHV and Orsay Virus Replication Levels Were Enhanced in rsd-2;rde-1 Double 
Mutants Compared to Either rsd-2 or rde-1 Single Mutants .................................................... 29 
3.4.4 ViRNAs Accumulated in rsd-2;rde-4 Double Mutants ................................................... 30 
3.4.5 Neither FHV nor Orsay Virus Replication Levels in rsd-2;rrf-1 Double Mutants Were 
Enhanced Compared to Those in rsd-2 Single Mutants ........................................................... 31 
3.4.6 Both FHV and Orsay Virus Replication Levels Were Decreased in the rsd-2;drh-2 
Double Mutants Compared to Those in rsd-2 Single Mutants ................................................. 32 
3.4.7 Both FHV and Orsay Virus Replication Levels Were Decreased in rsd-2;ergo-1 Double 
Mutants Compared to Those in rsd-2 Single Mutants .............................................................. 33 
3.5 Other Biological Functions of rsd-2 in C. elegans ............................................................. 34 
3.5.1 Transgene Can Be Silenced by viRNAs in the rsd-2 Mutant Strain ............................... 34 
3.5.2 GFP Was Silenced in the FR1fp; gfp;rsd-2 Mutant Strain by Exogenous GFP dsRNA . 35 
3.5.3 Rsd-2 Is Not Required for miRNA Biogenesis ................................................................ 36 
CHAPTER FOUR: CONCLUSIONS........................................................................................... 37 
CHAPTER FIVE: DISCUSSIONS .............................................................................................. 39 
REFERENCES ............................................................................................................................. 41 
VITA ............................................................................................................................................. 46 
 
 
 vi 
 
LIST OF FIGURES 
Figure 1.1 The anatomy of C. elegans (Girard, Fiedler et al. 2007). . ............................................ 1 
Figure 1.2 The life span of C. elegans at 20 °C (Girard, Fiedler et al. 2007).. ............................... 2 
Figure 1.3 Illustration of strategies for down-regulating genes in C. elegans (Jose and Hunter 
2007). ...................................................................................................................................... 4 
Figure 1.4 Genomic structure of Flock House Virus. ..................................................................... 7 
Figure 1.5 Schematic of genomic organization of Orsay virus (Felix, Ashe et al. 2011)............... 8 
Figure 1.6 Genomic positions of the wild type rsd-2 gene and the rsd-2 mutant alleles (Rogers, 
Antoshechkin et al. 2008). .................................................................................................... 11 
Figure 3.1 Strategy to trigger FHV replication in C. elegans.  ..................................................... 15 
Figure 3.2 Strategy to identify genes required for antiviral RNAi in C. elegans. ........................ 17 
Figure 3.3 Rsd-2 was screened out as a gene required for antiviral RNAi in C. elegans (Lu, Yigit 
et al. 2009). ........................................................................................................................... 18 
Figure 3.4 Rsd-2 is required for RDVI targeting FHV in C. elegans. .......................................... 19 
Figure 3.5 Rsd-2 is required for RDVI targeting Orsay virus in C. elegans. ............................... 20 
Figure 3.6 Wild type rsd-2 gene rescued RDVI in rsd-2 mutants carrying the FR1gfp transgene.
............................................................................................................................................... 22 
Figure 3.7 ViRNAs accumulated in the rsd-2 mutants.  ............................................................... 23 
Figure 3.8 GFP expression level was enhanced in rsd-2;rde-4 double mutants. ......................... 26 
Figure 3.9 FHV and Orsay virus replication levels were enhanced in rsd-2;rde-4 double mutants.
............................................................................................................................................... 26 
Figure 3.10 Rsd-2 and drh-1 function in separate RDVI pathways. ............................................. 28 
 vii 
 
Figure 3.11 FHV and Orsay virus replication levels were enhanced in drh-1;rsd-2 double 
mutants. ................................................................................................................................. 28 
Figure 3.12 GFP expression level was enhanced in rsd-2;rde-1 double mutants. ....................... 29 
Figure 3.13 FHV and Orsay virus replication levels were enhanced in rsd-2;rde-1 double 
mutants. ................................................................................................................................. 30 
Figure 3.14 ViRNAs accumulated in rsd-2;rde-4 double mutants. .............................................. 31 
Figure 3.15 FHV and Orsay virus replication levels in rsd-2;rrf-1 double mutants were similar to 
those in rsd-2 single mutants. ............................................................................................... 32 
Figure 3.16 FHV and Orsay virus replication levels were decreased in rsd-2;drh-2 double 
mutants compared to those in rsd-2 single mutants. . ........................................................... 33 
Figure 3.17 FHV and Orsay virus replication levels were decreased in rsd-2;ergo-1 double 
mutants compared to those in rsd-2 single mutants.  ............................................................ 34 
Figure 3.18 Rsd-2 is not important for viRNAs mediated transgene silencing.  .......................... 35 
Figure 3.19 GFP was silenced in the rsd-2 mutant strain. ............................................................ 35 
Figure 3.20 MiRNA-58 expression levels were not affected in rsd-2 mutants.  .......................... 36 
 
 
 
 
 
 
 
 
 
 viii 
 
ABSTRACT 
          RNA interference (RNAi) is a phylogenetically conserved gene regulation mechanism that 
modulates a wide variety of biological functions through suppressing gene expression at 
transcriptional or posttranscriptional levels (Bass 2000; Sharp 2001). One of the major natural 
functions of RNAi is antiviral defense in cytosol. RNAi directed viral immunity (RDVI) targets 
viral transcripts for destruction using small interfering RNAs (siRNAs) processed from viral 
replication intermediates, in the form of double-stranded RNA (dsRNA), as sequence guide (Lu, 
Maduro et al. 2005). Accumulating evidence suggests RDVI in the nematode worm 
Caenorhabditis elegans  begins with the biogenesis of virus-derived siRNAs (viRNAs) by DCR-
1 (Bernstein, Caudy et al. 2001; Duchaine, Wohlschlegel et al. 2006), a type III ribonuclease, 
and RDE-4, a dsRNA binding protein (Grishok, Pasquinelli et al. 2001; Knight and Bass 2001). 
Efficient destruction of viral transcripts guided by viRNAs is then orchestrated by several host 
factors that form distinct classes. Some of the known host factors downstream of viRNA 
biogenesis include Argonaute proteins (e.g. RDE-1) (Tabara, Sarkissian et al. 1999; Hammond, 
Boettcher et al. 2001; Parrish and Fire 2001), RNA-dependent RNA polymerases (e.g. RRF-1) 
and putative RNA helicases (e.g. DRH-1) (Tabara, Sarkissian et al. 1999). 
          To better understand worm RDVI, we have recently performed a genetic screen aiming to 
isolate novel host factors in the RDVI pathway. RSD-2 is one of our top candidates whose 
function in RDVI has been confirmed using corresponding genetic mutants in this study. RSD-2 
is a novel protein that is not conserved in fungi, plants, insects or vertebrates (Tijsterman and 
 ix 
 
Plasterk 2004). When the level of viral replication was accessed in double mutants that contain 
both the rsd-2 null allele and null allele corresponding to rde-1, rde-4 or drh-1, enhanced viral 
replication, as compared to respective single mutants, was observed. Since viRNAs can be 
readily detected in double mutants corresponding to rde-4;rsd-2, these observations together 
suggested that RSD-2 functions in a RDE-4-independent pathway for virus silencing. Since 
RSD-2 appears to be unique to the nematode kingdom, our study on the function and mechanism 
of RSD-2 may help reveal some unique features of the worm RDVI. 
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CHAPTER ONE: INTRODUCTION 
1.1 C. elegans as a Model Organism 
          C. elegans is a type of free-living nematode, typically 1 mm in-length, which feeds on 
bacteria, usually E. coli species (Wood 1988). They can be maintained in the lab by growing on 
agar plates with the E. coli as the food source (Stiernagle 2006). C. elegans has been one of the 
model organisms for research on biological sciences since 1974 (Epstein, Waterston et al. 1974; 
Waterston, Epstein et al. 1974).  
 
 
Figure 1.1 The anatomy of C. elegans (Girard, Fiedler et al. 2007). The hermaphrodites and 
males are different in their body size and structures such as the somatic gonad and tail. 
Numerous other tissues and organs are sexually dimorphous, especially the nervous system and 
musculature.  
 
          The basic anatomy of C. elegans includes mouth, pharynx, intestine, gonad, and 
collagenous cuticle (Riddle 1997). C. elegans has two sexes: hermaphrodites and males (Riddle 
1997). Hermaphrodites have two ovaries, oviducts, spermatheca, and a single uterus (Riddle 
1997). Males have a single-lobed gonad, vas deferens, and a tail specialized for mating. C. 
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elegans has five pairs of autosomes and one pair of sex chromosomes (Riddle 1997). 
Hermaphrodite C. elegans has a pair of sex chromosomes (XX), but the males have only one sex 
chromosome (X0) (Riddle 1997). Hermaphrodites can be maintained by self-fertilizing, and 
males can be produced by heat shock at 42 °C for around 45 minutes and maintained by crossing 
with hermaphrodites. Self-fertilized hermaphrodites can lay approximately 300 eggs, while the 
number can be above 1, 000 when fertilized by a male (Riddle 1997). 
          At 20 °C, C. elegans has an average life span of 2-3 weeks, and it needs around 14 hours, 
12 hours, 8 hours, 8 hours, 10 hours, and 8 hours to grow from embryonic development-L1-L2-
L3-L4-young adult-adult. For special, when stresses such as crowding or food limitation 
condition is encountered, L1 animals can enter into the dauer stage in which animals can survive 
without food for several months, and after the stresses disappear, the worms staying at the dauer 
stage can bypass both L2 and L3 stages and get into the L4 stage directly (Cassada and Russell 
1975; Albert and Riddle 1988).  
 
Figure 1.2 The life span of C. elegans at 20 °C (Girard, Fiedler et al. 2007). C. elegans has a 
short life cycle. The life cycle is temperature-dependent. C. elegans goes through a reproductive 
life cycle (egg to adult) in 5.5 days at 15°C, 3.5 days at 20°C, and 2.5 days at 25°C. 
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          The genomic sequence of C. elegans was obtained and published in 1998 (1998), and the 
remaining gaps were finished by 2002. The C. elegans genome sequence is approximately 100 
million base pairs long (Wood 1988). 
          Mutant C. elegans strains can be obtained through treatment of chemical mutagen such as 
Ethyl Methanesulfonate (EMS) or exposure to ionizing radiation (Epstein, Shakes et al. 1995; 
Jorgensen and Mango 2002), followed by genetically crossing with wild type C. elegans strain 
for several times to remove the possible undesired mutated genes based on the extent of used 
mutagenesis, and self-crossing to obtain the homozygous strain. Genetic cross among 
homozygous C. elegans with different genetic backgrounds can facilitate separation or 
combination of different genetic background to bring about new C. elegans strains with the 
genetic background we are interested in from their descendants. Transgenic C. elegans strains 
can be created through injection of the designed plasmid constructs to animals’ gonads followed 
by picking the desired strain from the next generation of treated animals (Mello, Kramer et al. 
1991). There is a large collection of C. elegans genetic mutants, and they can be ordered from 
the Caenorhabditis Genetics Center (CGC) or be asked from the labs which generated those 
mutants (Rogers, Antoshechkin et al. 2008). 
          C. elegans genes can be down-regulated using many different procedures such as feeding 
worms with the bacteria producing corresponding dsRNAs, transforming the worm with the 
sequence which can be transcribed as dsRNAs, or artificially introducing synthesized dsRNAs 
into animals by either soaking or injection (Jose and Hunter 2007). 
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Figure 1.3 Illustration of strategies for down-regulating genes in C. elegans (Jose and 
Hunter 2007). (A) Feeding the worms with transgenic bacteria expressing dsRNAs 
complementary to the gene of interest. (B) Worms can be made transgenic to produce specific 
dsRNAs in vivo. (C) Synthesized dsRNAs can be introduced to worms through either injection 
or soaking.  
1.2 RNA Interference  
          RNA interference (RNAi), or RNA silencing is a novel mechanism found in eukaryotic 
cells that regulates gene expressions (Hammond, Caudy et al. 2001; McManus and Sharp 2002; 
Tomari and Zamore 2005), and three main types of small RNAs, microRNA (miRNA), small 
interfering RNA (siRNA), and piwi-interacting RNA (piRNA), were found to play important 
roles in different RNAi pathways (Xie, Johansen et al. 2004; Ruby, Jan et al. 2006).  
          For siRNA-mediated RNAi pathway, RNAi is initiated by dsRNA (Fire, Xu et al. 1998). 
Subsequently, dsRNAs will be diced by Dicers into short fragments of 20-30 nts called small 
interference RNAs (siRNAs) (Ding and Voinnet 2007; Aliyari and Ding 2009). Thereafter, the 
passenger strand will be degraded and the guide strand will be incorporated into the RNA-
induced silencing complex (RISC) for target selection, eventually resulting in either degradation 
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or translation arrest of the targets based on the extent of sequence complementarities between the 
guide strand and its targets (Hammond, Bernstein et al. 2000; Hammond 2005). Some organisms 
such as plants and C. elegans are able to produce RNA-dependent RNA polymerases (RdRPs), a 
class of enzymes responsible for generation of secondary siRNAs, which can also silence target 
transcript expression (Sijen, Fleenor et al. 2001; Pak and Fire 2007; Sijen, Steiner et al. 2007). 
As a result, RNAi in these organisms is very efficient despite the initially small amount of 
siRNAs, unlike organisms, such as mammals, which do not produce RdRPs. In addition, some 
organisms have structure channels between adjacent cells, e.g. plasmodesmata in plants, or 
protein channels in cell membranes, e.g. SID-1 protein in C. elegans, causing RNAi silencing 
signals being able to travel from cell to cell. Consequently, RNAi in these organisms is capable 
of spreading systemically.   
          Naturally, RNAi-related mechanisms contribute to development, transposon control, and 
antiviral silencing (Grishok, Pasquinelli et al. 2001; Boutet, Vazquez et al. 2003). Since the 
silencing effect is highly specific and robust, RNAi has been used as a genetic tool to suppress 
the expression of genes of our interest, mainly through introducing corresponding artificial 
dsRNAs into cell cultures or living organisms. Moreover, RNAi has also been used in reverse 
genetic to identify genes required for a particular cellular pathway or an event by systemically 
silencing each gene in the cell in a large-scale genetic screen.   
         In C. elegans, RNAi was known as efficient, transitive and systemic, and it can be induced 
by feeding, soaking, or injecting the organism with exogenous dsRNA, or through integrating the 
DNA sequence, which is able to generate dsRNA after transcription, into worm’s genome 
(Figure 1.3). 
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1.3 RNAi Directed Viral Immunity (RDVI)  
          Antiviral defense is one of the natural functions of RNAi (Boutet, Vazquez et al. 2003; 
Ding, Li et al. 2004; Deleris, Gallego-Bartolome et al. 2006; Wang, Aliyari et al. 2006). 
Infecting viruses in organisms can generate long dsRNAs during the viral replication. In plants 
and invertebrates, Dicers will cleave viral dsRNAs into short fragments of viral siRNAs 
(viRNAs), which are structurally similar to the siRNA duplex intermediate (Boutet, Vazquez et 
al. 2003). Afterward, one strand of the viRNA duplex will be loaded into RNA induced silencing 
complex (RISC) and used as sequence guide to find its complementary targets, the viral RNA 
transcripts. Consequently, the catalytic component of RISC, Argonaute protein will cleave the 
viral transcripts, resulting in the silencing of replicating viruses (Vastenhouw and Plasterk 2004). 
In some organisms such as plants and nematodes, the production of secondary viRNAs by the 
organisms’ own RdRPs can bring about great increase of the amounts of viRNAs available to 
RISC, leading to the silencing effect of antiviral RNAi being further amplified (Aoki, Moriguchi 
et al. 2007; Diaz-Pendon, Li et al. 2007).  
1.4 Flock House Virus (FHV) 
          We choose FHV as our model virus because FHV can replicate in yeast, plant, insect and 
mammalian cells and it is one of the well-studied viruses (Johnson and Ball 1999; Venter and 
Schneemann 2008). FHV contains two genomic segments, RNA1, which encodes the viral RNA 
dependent RNA polymerase (RdRP) (Figure 1.4A) and RNA2, which encodes precursor protein 
of the viral coating protein (Figure 1.4B). RNA1 can replicate autonomously in the absence of 
RNA2 whose replication is dependent on RNA1. At the 3' end of RNA1, there is a subgenomic 
RNA3 which is transcribed during RNA1 replication from an internal site of the complementary, 
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replicative intermediate of RNA1 (Figure 1.4A). RNA3 is not required to initiate FHV infection 
and it encodes the RNAi suppressor protein B2.  
 
Figure 1.4 Genomic structure of Flock House Virus. (A) Expression of wild type FHV RNA1 
(FR1) produces FHV RdRP and expression of FHV RNA3 (FR3) produces RNAi suppressor B2 
protein of FHV. (B) Expression of wild type FHV RNA2 (FR2) produces the precursor protein 
of FHV. 
1.5 Orsay Virus 
          Orsay virus is a novel RNA virus distantly related to known nodaviruses, and it was 
isolated from wild C. elegans strain JU1580 with abnormal morphological phenotypes in 
intestinal cells (Felix, Ashe et al. 2011). RT-PCR assay and Illumina/Solexa high-throughput 
sequencing were utilized to confirm the presence of Orsay virus in the infected animals, and Orsay 
viral RNA was detected in intestine and somatic gonad, through fluorescent in situ hybridization 
(FISH) using a probe complementary to the sense RNA1 segment of Orsay virus (Felix, Ashe et 
al. 2011). The observation that Orsay virus infection invokes a small RNA response in JU1580 
animals indicates RNAi mechanisms provide antiviral immunity to C. elegans and Orsay virus 
infection of mutant animals can be used to confirm genes essential for antiviral defense (Felix, 
Ashe et al. 2011). Also, the observation that Orsay virus accumulation increases in RNAi mutant 
strains, compared to that in wild type N2 worms, provides a completely natural setting to 
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demonstrate the roles of RDVI in C. elegans. Thus, all of our results were confirmed through 
Orsay virus infection.  
          The genomic structure of Orsay nodavirus is very similar to that of FHV. The genomic 
structure of Orsay nodavirus is very similar to that of FHV. Both viruses contain two genomic 
segments, RNA1 which encodes RNA dependent RNA polymerase, and RNA2 which encodes 
the precursor protein of viral coating protein at its 5' end. However, no predicted RNA3 sequence 
was found at the 3’ end of Orsay virus RNA1; instead, it seems that there is another open reading 
frame at 3’ end of Orsay virus RNA2. For detection of Orsay virus infection, we prepared cDNA 
probes that are complementary to the segment of Orsay virus RNA1. 
 
Figure 1.5 Schematic of genomic organization of Orsay virus (Felix, Ashe et al. 2011). The 
RNA1 segment (2,680 nucleotides) encoded a predicted open reading frame of Orsay virus 
RdRP, and the RNA2 segment was predicted to encode a capsid protein at its 5’ end as well as a 
second ORF at the other end.  
1.6 The rsd-2 Gene 
        Originally, rsd-2 was screened out as a gene required for RNAi spreading from somatic 
cells to germline cells in C. elegans and the mutant animals showed no any development defect 
(Tijsterman and Plasterk 2004). The observation that rsd-2 mutants showed phenotype when fed 
with dsRNA against somatic genes, but not germline genes, indicates that rsd-2 mutants are 
sensitive to RNAi against somatic genes, but not to RNAi targeting germline genes. In other 
words, mutations in the rsd-2 gene do not affect somatic RNAi (Tijsterman and Plasterk 2004). 
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They don’t appear defective in the initial uptake of dsRNA from the gut into somatic tissues but 
they fail to further distribute the dsRNA to the germline (Tijsterman and Plasterk 2004).  
          Later on, it was discovered that the function of rsd-2 in RNAi is very complex and 
environmentally regulated. First, rsd-2 gene has mosaic effect in both somatic RNAi and 
germline RNAi based on the observations after increasing the range of genes targeted by feeding 
RNAi. Second, the rsd-2 mutants show environmentally sensitive defects in cell autonomous 
RNAi elicited from transgene-delivered dsRNAs. Third, rsd-2 has essential roles in maintaining 
chromosome integrity, such as transposon silencing in some unfavorable environment (Wang, 
Aliyari et al. 2006).  
          RSD-2 protein is a novel protein with no close homolog found in other organisms, thus no 
indication of its molecular function so far. RSD has an N-terminal domain that exists in three 
copies (Tijsterman and Plasterk 2004). RSD-2 protein was found to exist in multiple cellular 
compartments, including the nucleolus and cytoplasmic compartments, and to most frequently 
interact with RSD-6 (Wang, Aliyari et al. 2006).  
          The rsd-2 gene is located on chromosome IV. Two alleles of rsd-2 were used in my study: 
tm1429, which contains 451 base pair (bp) deletion, and pk3307, which contains a point 
mutation(c to t) (Figure 1.6). The tm1429 allele was isolated using TMP/UV as mutagen by 
Shohei Mitani’s lab at the Tokyo Women’s Medical College, and the pk3307 allele was isolated 
using EMS as mutagen by Hubrecht Laboratory (Rogers, Antoshechkin et al. 2008). 
          The wild type RSD-2 coding sequence is shown below. Pink colored sequences are 
flanking sequences, and capitalized sequences are deleted sequences in the tm1429 allele. 
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tcaacccaaaattctcacaaatctcttggtactgccatgtttagaaccattccgtggttcatttggaagccgagagatacttttcgcgccaagac
catttttcctgctcaattgataaatgttatcttcatattttcccattacttgcaagtaatgatccaagtcatcgatgaattgtcttttaagtggagctact
gctttgaaacatgctttcagtggatcaccgtattgtaccctgaaaaatccaaaaattaactttttttttgcattttgcagcattatacaacataaaaaa
cacgttttcaagatttagtggaaaacgagatctacgaaaatatgatctacgaaaagtggatctatcaaaacaagatctacattttcaggatctgg
cgtgccaacggcggttttcgcagttttctcgaagaaaatcgaaacaacgatgctccaatattatgcatcgcgcgttgtttagcgttttccagaag
tttttttttcaaaaaAAGCTTTTCTGGACGCTAAACAACGCGCGATGCGTAATTGTTTTGGTAGATCTCCAAATTGTA
GATCTTATTTTGGTAGATCTCCAAATTGTAGATCATGTTTTGGTAGATCTCCAAATTGTAGATATTGTTTTCG
TAAATCTTCTTTCCGTAGATCTTGTTTCCGGGTAAATCTTGAAAACGTGATGCCTCCTCGCTTACATTGTAAT
CTGAGTACTGTAGACGGTTCCAAATTCAAAATCTCCAGTTATTCGAGGAATCTCCACAAATCCATATCGATC
CGATACACCGACTTCCTTATTGTATGATTTGTGCTTTGGATTTGACGAGAAAATCACGTTTGCAGAGATCTTC
GGAACATCATCAGACGAGAAAACTGCCCCCTCACACTCTGAAACTCGTGCCGATTGAGTTTGAATCGACGTC
TTTCCATAATTATTTCCAGCCGCTACAGCCGCTAtgaactggaaaattccatatggacgaagtctgcaaagagttttgatgacat
tgaaaattggtgctcgccaactaacggaacggttactccagctgtgcaaattgtcataagcttcaactgagtcgtctcgaaaccgacacattc
gtcattgtccacgttgagcacaattacagaatgatctaccccgacttttgaagacgaaattgtggacgaacttgattcggacagagattgggg
cattcttccaaatgttctggaattaataaaaatatatgtttcaaattttatcgttttattggactcaaaattgcatgaaaacaccgaatttcttaatgaa
acttcttgaaaacttctctttaaaaaatttatggcggctcaaaaaatgactttaaattagttaaaatttgaaatttgaccaacttgtcaagtggctgg
aaactgattattaattatcatgagttttcaactcgatttaggtattttattttaaaaaaaaacca (Rogers, Antoshechkin et al. 
2008) 
          The sequences of the plus strand of mutant rsd-2 in strain tm1429 are as followings. 
tcaacccaaaattctcacaaatctcttggtactgccatgtttagaaccattccgtggttcatttggaagccgagagatacttttcgcgccaagac
catttttcctgctcaattgataaatgttatcttcatattttcccattacttgcaagtaatgatccaagtcatcgatgaattgtcttttaagtggagctact
gctttgaaacatgctttcagtggatcaccgtattgtaccctgaaaaatccaaaaattaactttttttttgcattttgcagcattatacaacataaaaaa
cacgttttcaagatttagtggaaaacgagatctacgaaaatatgatctacgaaaagtggatctatcaaaacaagatctacattttcaggatctgg
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cgtgccaacggcggttttcgcagttttctcgaagaaaatcgaaacaacgatgctccaatattatgcatcgcgcgttgtttagcgttttccagaag
tttttttttcaaaaatgaactggaaaattccatatggacgaagtctgcaaagagttttgatgacattgaaaattggtgctcgccaactaacggaac
ggttactccagctgtgcaaattgtcataagcttcaactgagtcgtctcgaaaccgacacattcgtcattgtccacgttgagcacaattacagaat
gatctaccccgacttttgaagacgaaattgtggacgaacttgattcggacagagattggggcattcttccaaatgttctggaattaataaaaata
tatgtttcaaattttatcgttttattggactcaaaattgcatgaaaacaccgaatttcttaatgaaacttcttgaaaacttctctttaaaaaatttatggc
ggctcaaaaaatgactttaaattagttaaaatttgaaatttgaccaacttgtcaagtggctggaaactgattattaattatcatgagttttcaactcg
atttaggtattttattttaaaaaaaaacca (Rogers, Antoshechkin et al. 2008) 
 
 
Figure 1.6 Genomic positions of the wild type rsd-2 gene and the rsd-2 mutant alleles 
(Rogers, Antoshechkin et al. 2008). The tm1429 mutant allele contains a 451 bp deletion and 
the pk 3307 mutant allele contains a nucleotide substitution of c to g.   
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CHAPTER TWO: MATERIALS AND METHODS 
2.1 C. elegans Genetics and Culture  
          All worm strains were propagated and maintained using standard protocols. The food for 
the worms is prepared using E. coli strain OP50 or HT115. The Bristol strain N2 was used as the 
standard wild-type strain. Alleles used in this study are all derived from N2 and include rde-1 
(ne300), rde-4 (ne337), drh-1 (tm1329), drh-2 (ok951), rrf-1 (pk1417), ergo-1 (tm1860), and 
rsd-2 (tm1429 and pk3307). The genotypes of the worm strains containing single or double 
mutations were confirmed by PCR and/or feeding RNAi targeting skn-1. The strain used to 
maintain Orsay virus is JU1580 from Dr. David Wang’s lab. 
2.2 Transgenic Construct and Transgenic Worms 
          The FR1gfp replicon was derived from pFR1-3 through replacing most of the B2 coding 
sequence (the nucleotides 2,802–3,001 of RNA1) by the full length enhanced GFP coding region 
as described previously (Li, Li et al. 2004; Lu, Maduro et al. 2005). This method created a 
translational fusion of GFP with N-terminal 23 amino acids of B2 and around 200 nucleotides 
(nts) deletion from the B2 open reading frame. Transgenic animals carrying the FR1fp replicon 
was generated by microinjecting into wild type strain with FR1fp, in which the 3’ end of 
enhanced GFP coding sequence was used to replace B2 coding sequence in pFR1-3 instead of 
the full length enhanced GFP sequence. Psur-5::GFP contains a constitutive sur-5 promoter 
followed by full length enhanced GFP coding sequence. Similarly, Psur-5::RSD-2 contains wild 
type RSD-2 coding sequence driven by the sur-5 promoter. 
             Animals were made transgenic by gonadal microinjection following standard protocol 
(Mello, Kramer et al. 1991).  Briefly, FR1gfp plasmid (final concentration 5 mg/ml) was mixed 
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with the rol-6D plasmid pRF4 (final concentration 100 mg/ml) for injection into wild-type N2 
animals. Integrated lines were then generated by treating about 50 transgenic hermaphrodites 
with 3,500 rad of γ-rays from a 137Cs source, followed by screening for integrated animals in the 
F2 generation.  
2.3 Orsay Virus Infections 
          The Orsay virus stock was maintained using C. elegans isolate JU1580. To prepare Orsay 
virus inoculum, Orsay virus particles was extracted by first washing off infected JU1580 animals 
from 6 cm culture plates using distilled water. Then, the animals were precipitated by 
centrifugation. Next, the virus containing supernatant solution was collected and filtered through 
0.2 µm filters to remove other possible contaminants. At last, 5-10 times concentrated E. coli 
solution was mixed with the filtered liquid, and aliquots were dropped on the middle of the agar 
plates for culturing C. elegans strains. As soon as the Orsay virus containing E. coli food in the 
culture plates becomes dry, worms can be grown in these plates for 2 to 3 days to be infected by 
Orsay virus.  
2.4 RNAi Experiments 
          Feeding RNAi targeting gfp or skn-1 was performed by feeding worms with E. coli food 
which can express dsRNAs corresponding to gfp or skn-1 coding sequence respectively. IPTG at 
final concentration of 2 mM was used for the induction of dsRNA expression.  
2.5 RNA Preparation and Northern Blot Analysis 
          Total RNA was prepared using the TRI Reagent method (MRC, Inc.). RNA concentrations 
were normalized and used for northern blot analysis according to standard protocols described 
previously (Li, Li et al. 2002) using labeled cDNA probe corresponding to the 3’ end 387 nts of 
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GFP, which will hybridize to both RNA1 and RNA3 of FHV. For high molecular weight viral 
RNA detection, 3 to 6 µg total RNA per lane was loaded in 1.2% agarose gel. For small RNA 
analysis, 10 to 20 µg of enriched small RNA samples per lane was resolved using 15% 
acrylamide denaturing gel along with chemically synthesized DNA oligos as size references. 
After electrophoreses, the RNA samples were transferred onto Hybond N+ membrane 
(Amersham Bioscience) and UV cross-linked using 1800 µJ/cm
2
 as output power 
(SpectroLinker). For northern blot detection of FHV and full length GFP transcripts, cDNA 
probes were prepared by labeling GFP DNA fragments using AlkPhos Direct Labeling Reagents 
(GE Healthcare Company). For (-)viRNA analysis, the membranes were hybridized with 
synthesized oligo DNA probes, which have the same polarity of FHV RNA1 and were labeled 
using DIG kit (Roche Company), in the hybridization buffer. Sequence for oligo probes used for 
the detection of miR-58 is ATTGCCGTACTGAACGATCTCA. 
2.6 RSD-2 Functional Rescue Experiment 
          The RSD-2 functional rescue was carried out by injecting the rsd-2 mutants (tm1429) 
carrying the FR1gfp replicon with the Psur-5::RSD-2 construct. The F1 progenies were then 
examined for GFP expression after being maintained at 25 °C for 36 hours post induction of the 
FR1gfp replicon replication. In the F1 progenies that carry the wild type rsd-2 extrachromosomal 
array, complete loss or significant reduction of green fluorescence expression was considered as 
successful rsd-2 functional rescue. 
2.7 Imaging Microscopy 
          GFP fluorescence images were collected using an AmScope MT1000 camera mounted on 
an Olympus IMT-2 microscope.  
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CHAPTER THREE: STRATEGIES TO STUDY RDVI IN C. ELEGANS 
AND RESULTS 
3.1 Initiate FHV Replication in C. elegans  
          The FHV replication in C. elegans was initiated using a strategy illustrated in Figure 3.1.  
It has been shown that Northern blot hybridizations could detect high level accumulation of FHV 
RNA1 and RNA3 in worms carrying the FR1-3 transgene described previously (Lu, Maduro et 
al. 2005).  
 
Figure 3.1 Strategy to trigger FHV replication in C. elegans. Heat induction can activate the 
promoter of the FR1 transgene so that the transcription of the following sequence will be driven. 
Then the ribozyme will be produced. After the ribozyme cleaves itself, the FHV plus strand will 
be produced and translated to FHV RdRP. Next, with the help of FHV RdRPs, the transgenic 
FHV will be able to replicate. 
 
          The high level accumulation of viral RNAs detected in transgenic worm strains arouse 
from active RNA replication because in the absence of RNA replication the initial heat-induced 
transcripts were below the limit of detection in worms two days post heat induction. FHV RNA2 
accumulation can also be detected in FR1-3;FR2 transgenic worms after heat induction. 
Therefore, detection of FHV genomic RNA1, RNA2 and subgenomic RNA3 in these worm 
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strains provide strong evidences that C. elegans supports complete replication of the FHV RNA 
genome (Lu, Maduro et al. 2005). 
          To further confirm that antiviral RNAi contributes to FHV silencing in C. elegans, FR1-3 
ΔB2 transgene was introduced to well-known RNAi deficient mutant worm strains such as rde-1 
mutant strain, which is very healthy, unlike many other RNAi mutant strains (Lu, Maduro et al. 
2005). In contrast to undetectable accumulation of FHV RNA1 and 3 in wild type N2 worms 
carrying FR1-3 ΔB2 transgene, northern blot analysis showed abundant accumulation of FHV 
RNA1 and 3 in the FR1-3 ΔB2 transgenic rde-1 mutant strain (Lu, Maduro et al. 2005). Thus, 
the mutant FHV RNA1 produced from FR1-3 ΔB2 transgene is not defective in self-replication, 
suggesting that the decreased accumulation of FHV RNA1 and 3 in N2 worms resulted from 
induction and clearance of viral RNAs by antiviral silencing in an rde-1-dependent siRNA 
pathway. Taken together, all these evidences confirmed that antiviral RNAi contributes to FHV 
silencing in C. elegans, making FHV transgenic C. elegans strains ideal model system to study 
the antiviral RNAi.  
3.2 Identify Genes Required for Antiviral RNAi in C. elegans by Feeding RNAi 
          Previously, a derivative of the infectious full-length cDNA clone of FHV RNA1, FR1gfp 
(Li, Li et al. 2004), in which the B2 coding sequence is replaced by GFP coding sequence has 
been shown to replicate autonomously and produce green fluorescence (Figure 3.2). The inserted 
GFP coding sequence fused with the N-terminal 23 codons of B2 is expressed only from the 
recombinant RNA3 produced during FR1gfp replication, but not directly from FR1gfp because 
its initiation codon is more than 2.7 kb away from the 5’-terminus of FR1gfp RNA (Figure 3.2). 
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FR1gfp is defective in RNAi suppression because of the loss of B2 production but not in 
replication.  
 
Figure 3.2 Strategy to identify genes required for antiviral RNAi in C. elegans. In the 
FR1gfp transgene, GFP sequence was used to replace part of RNA3 sequence so that FHV 
replication levels can be visualized. Next, feeding RNAi was used to down-regulate specific C. 
elegans genes. In the normal condition, after heat induction FHV would not replicate well in the 
absence of RNAi suppressor B2, while in case the C. elegans antiviral RNAi system does not 
function appropriately either, the FHV transgenic viruses should restore their ability to replicate; 
thus, through comparing the GFP expression levels of the worms, the antiviral RNAi gene 
components can be selected out.  
 
          As a result, the FR1gfp replication and gfp expression from the FHV replicon occur only 
after antiviral RNAi is suppressed by either B2 co-expression or genetic disruption of the 
antiviral RNAi pathway in both cultured fruit fly and mosquito cells (Li, Li et al. 2004). To 
develop a model for genetic screens to identify new genetic components in antiviral RNAi, we 
generated C. elegans strains bearing a chromosomally integrated FR1gfp transgene under the 
control of a heat-inducible promoter (Figure 3.2).  
          We found that very little green fluorescence was observed in FR1gfp worms after the heat 
induction of the FHV replicon transgene (Figure 3.3 top left). In contrast, bright green 
fluorescence was observed throughout the worm body after FR1gfp transgenic worms were fed 
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on E. coli food that expresses rde-1 dsRNA (Figure 3.3 top middle), which depletes the mRNA 
of rde-1 in a process called feeding RNAi (Timmons, Court et al. 2001). Bright green 
fluorescence was also observed in FR1gfp worms after a loss-of-function rde-1 allele was 
introduced into FR1gfp worms by genetic crosses (Lu, Yigit et al. 2009). Northern blot 
hybridizations confirmed the abundant accumulation of the chimeric FHV RNA1 and RNA3 in 
FR1gfp worms after rde-1 depletion, but FR1gfp replication was inhibited in wild-type N2 
worms (Lu, Yigit et al. 2009). Thus, productive FR1gfp replication and abundant GFP 
expression in FR1gfp transgenic worms depend on the genetic disruption of the antiviral RNAi 
pathway, suggesting that FR1gfp transgenic worms could be used to screen for new genetic 
components in the antiviral RNAi pathway by feeding RNAi (Lu, Yigit et al. 2009). Rsd-2 was 
identified as one of the candidates using this strategy (Figure 3.3). 
 
Figure 3.3 Rsd-2 was screened out as a gene required for antiviral RNAi in C. elegans (Lu, 
Yigit et al. 2009). Green fluorescence was detected in FR1gfp transgeneic worms after feeding 
RNAi targeting specific genes or the commonly used L4440 vector. Photographs were taken 48 
hours after induction of the replicon replication. 
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3.3 Rsd-2 Is Required for Antiviral RNAi in C. elegans 
3.3.1 Rsd-2 Is Required for RNAi Targeting FHV in C. elegans 
          To confirm that rsd-2 is indeed required for RDVI, the FR1gfp replicon transgene was 
introduced to rsd-2 mutants containing different alleles through genetic crosses. After heat 
induction, the rsd-2 mutant strains showed the similar brightness of GFP as the drh-1 mutant 
strain which is defective in RDVI (Lu, Yigit et al. 2009) (Figure 3.4A, compare the top two with 
the right bottom), suggesting that rsd-2 is indeed required for RDVI targeting FR1gfp. Northern 
blot hybridization further confirmed that FHV accumulates to similar levels in rsd-2 mutants as 
those in drh-1 mutants (Figure 3.4B). All these observations confirmed that rsd-2 is indeed a 
gene required for RDVI in C. elegans. 
 
Figure 3.4 Rsd-2 is required for RDVI targeting FHV in C. elegans. (A) Detection of green 
fluorescence in FR1gfp transgenic worms 48 hours after induction of the replicon replication. (B) 
Accumulation of FR1gfp genomic (RNA1) and subgenomic RNA (RNA3) by northern blotting 
in FR1gfp transgenic worms 48 hours post heat induction. Methylene blue staining of total RNA 
was provided to show equal loading. 
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3.3.2 Rsd-2 Is Required for RDVI Targeting Orsay Virus in C. elegans 
         Orsay virus is a natural viral pathogen of C. elegans. To find out whether rsd-2 is a gene 
required for RDVI under natural condition, we inoculated wild type N2 worms, rsd-2 mutants 
containing distinct alleles (tm1429 and pk3307), and drh-1 mutants with Orsay virus. As shown 
in Figure 3.5, Orsay virus accumulated to high levels in rsd-2 mutants and drh-1 mutants but low 
levels in the wild type N2 worms (Figure 3.5A, compare the lane 2, 3 and 4 with the lane 1). RT-
PCR detection also confirmed the high-level accumulation of Orsay virus in rsd-2 mutants 
(Figure 3.5B). Taken together, these results confirmed that rsd-2 is required for RDVI under 
natural condition. 
 
Figure 3.5 Rsd-2 is required for RDVI targeting Orsay virus in C. elegans. (A) Detection of 
the Orsay virus genomic RNA1 accumulation levels by northern blotting in the worms grown on 
Orsay virus particle containing food for 2-3 days. Methylene blue staining of total RNA was 
provided to show equal loading. (B) Confirmation of the Orsay virus replication in worms by 
using RT-PCR to get two different DNA segments which were transcribed reversely from Orsay 
viral RNAs, using two different pairs of primers. Following RT-PCR, DNA gel electrophoresis 
was preformed and photographed. The sizes of these two DNA fragments are 1.2 and 1.3 kb 
respectively. 
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3.3.3 Wild Type rsd-2 Can Rescue RDVI in rsd-2 Knockout Mutants   
          To further confirm that it is the rsd-2 null alleles, but not any other null alleles, that are 
responsible for the loss of RDVI in the rsd-2 mutants used in the test described in Figure 3.5, we 
checked FR1gfp replication in rsd-2 mutants (tm1429) transgenic for Psur-5::RSD-2 (Materials 
and Methods 2.2). We reasoned that if it were the rsd-2 null alleles, but not any other null alleles, 
that are responsible for the loss of RDVI in the rsd-2 mutants, ectopic expression of wild type 
RSD-2 coding sequence in the rsd-2 mutants will restore RDVI. 
          To test this hypothesis, the wild type rsd-2 expressing construct (Psur-5::RSD-2) was co-
infected with an mCherry reporter construct, which directs mCherry expression in pharynx, into 
the rsd-2 mutants carrying the FR1gfp replicon transgene. Since, in most cases, the 
extrachromosomal arrays produced through gonad injection can only be randomly passed on to 
the next generation, as a result, within each generation of the transgenic lines, there are worms 
that do not carry the extrachromosomal arrays thus can serve as internal negative control. As 
shown in Figure 3.6A, within each transgenic line, clear correlation between reduced GFP 
expression and red fluorescence in pharynx produced by the reporter transgene was observed, 
suggesting that ectopic expression of wild type RSD-2 coding sequence restored RDVI in the 
rsd-2 knockout mutants.  
          As a reconfirmation, we checked FR1gfp replication in the chromosomal integrants 
corresponding to the wild type rsd-2 transgene using northern blot. We observed that, in contrast 
to the high-level replication of FR1gfp in the rsd-2 mutants, the FR1gfp replication was 
significantly suppressed in rsd-2 mutants containing the integrated transgenes corresponding to 
the wild type RSD-2 coding sequence (Figure 3.6B). These observations together confirmed that 
it is the rsd-2 null alleles that results in the loss of antiviral silencing in the rsd-2 mutants. 
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Figure 3.6 Wild type rsd-2 gene rescued RDVI in rsd-2 mutants carrying the FR1gfp 
transgene. (A) Detection of green fluorescence in FR1gfp transgenic worms with and without 
the extrachromosomal array that has copies of wild type rsd-2 gene which rescue a loss-of-
function mutation in the endogenous copies of rsd-2 48 hours after induction of the replicon 
replication. The array also expresses mCherry as a marker gene, from the mal2::mCherry 
construct in which mal2 is a promoter that only functions in the pharyngeal muscle cells of C. 
elegans and mCherry is a protein that can emit red fluoresence. Based on which animal’s 
pharynx shows red under the fluorescence microscope, the marker allows us to differentiate 
which animal contains the extrachromosomal array and which animal does not. (B) 
Accumulation of FR1gfp genomic (RNA1) and subgenomic RNA (RNA3) by northern blotting 
in the FR1gfp transgenic N2, rsd-2 mutant, rsd-2 mutant carrying integrated wild type rsd-2, 
drh-1 mutant, and rsd-2 mutant carrying non-integrated wild type rsd-2 worms 48 hours post 
heat induction. Methylene blue staining of total RNA was provided to show equal loading. 
         
3.3.4 Rsd-2 Is Not Required for viRNA Biogenesis  
         Rsd-2 was originally identified as a host factor responsible for systemic spreading of RNAi 
in C. elegans (Tijsterman and Plasterk 2004). Currently, how rsd-2 contributes to RDVI remains 
largely unknown. As an effort to address this question, we decided to determine whether rsd-2 is 
required for viRNA biogenesis. To this end, the small RNAs from N2, rrf-1, rde-1, rde-4, drh-1 
and rsd-2 strains were extracted and northern blot hybridizations were performed to check the 
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viRNA levels in these strains. We probed for viRNAs of the antigenomic polarity, instead of 
viRNAs of genomic polarity, because probing for viRNAs of the genomic polarity resulted in a 
smear and no discrete bands were detected in any of the worm strains tested either before or after 
transcriptional induction of FR1gfp (Lu, Yigit et al. 2009).  
 
Figure 3.7 ViRNAs accumulated in the rsd-2 mutants. Analysis of the (-)viRNAs 
accumulation levels in the FR1gfp transgenic wild type and single knockout worm mutants 48 
hours post heat induction. 15 µg of total small RNAs was loaded in each lane. DIG-labeled DNA 
oligos complementary to viRNA and miRNA were used as the probes. The same membrane was 
probed for miR-58 after stripping as the loading control. 
 
         The viRNAs were undetectable in wild-type worms, which may be due to the viral 
replication inhibition and thus lower levels of viral dsRNA for dicing in these worms. However, 
we detected viRNAs in the rsd-2 strains (Figure 3.7), indicating that the rsd-2 gene is 
dispensable for viRNA biogenesis.       
3.4 Delineate an rsd-2-dependent Genetic Pathway That Contributes to RDVI in C. elegans  
         The predominant model for antiviral silencing is the canonical dsRNA-siRNA pathway of 
RNAi, which is initiated by viral double-stranded replicating intermediates. The Sole RNase III 
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enzyme Dicer of C. elegans will cleave the viral dsRNAs into primary viRNAs, which will be 
loaded into the RISC complex and direct the silencing of viral transcripts. The RdRP in C. 
elegans can use the cleaved viral RNAs as templates to produce secondary viRNAs, which can 
be further used to silence viral transcripts, so that antiviral RNAi effects can be amplified. The 
followings are some discoveries on the antiviral RNAi pathway in C. elegans. First, the 
observation that Dicer was required for anti-VSV in C. elegans cells (Schott, Cureton et al. 2005) 
suggests that Dicer is required for antiviral silencing in C. elegans. Second, dsRNA-binding 
proteins (dsRBPs) are also required by Dicer to play its role in RNAi. For example, in the 
exogenous dsRNA initiated RNAi (exo-RNAi) pathway in C. elegans, the dsRBP, RDE-4, 
cooperates with Dicer during cleaving long dsRNAs to siRNAs, although it is not essential in the 
following steps (Parker, Eckert et al. 2006). Furthermore, RDE-4 was found to be required for 
viRNAs biogenesis in the RDVI pathway of C. elegans (Lu, Yigit et al. 2009). Third, a DEXH-
box helicase protein DRH-1 and an Argonaute protein RDE-1 were pulled down together with 
RDE-4 and DCR-1 in the exo-RNAi pathway in C. elegans, through immunoprecipitation 
(Tabara, Yigit et al. 2002), suggests that DCR-1, RDE-4, DRH-1, and RDE-1 may interact with 
each other to function in the exo-RNAi pathway in C. elegans. What’s more, DRH-1 and RDE-1 
were found as requirements for activity of viRNAs, and both were found working downstream of 
RDE-4 in RDVI in C. elegans (Lu, Yigit et al. 2009). Fourth, Dicer-related helicase protein 
DRH-2 and Argonaute protein ERGO-1 were found as negative regulators of antiviral RNAi in 
C. elegans (Lee and Sinko 2006; Lu, Yigit et al. 2009). 
          To determine the genetic pathway that involves rsd-2, six double mutants carrying FR1gfp 
transgene by genetic crosses, rsd-2;rde-4, rsd-2;drh-1, rsd-2;rde-1, rsd-2;rrf-1, rsd-2;drh-2, rsd-
2;ergo-1 were created. We observed that both FHV and Orsay virus replication levels in the rsd-
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2;rde-4 and rsd-2;drh-1 double mutants were enhanced compared to corresponding single 
mutants, suggesting that rsd-2 works in an RDVI pathway different from that involves rde-4 and 
drh-1. In contrast to the discovery of no viRNAs detected in the rde-4 single mutants and rde-
4;drh-1 double mutants (Lu, Yigit et al. 2009), we found viRNAs accumulated in the rsd-2;rde-4 
double mutants, further corroborating our conclusion that rsd-2 works in an rde-4-independent 
RDVI pathway. Furthermore, our observations that both FHV and Orsay virus replication levels 
were not enhanced in rsd-2;rrf-1 double mutants, suggested rsd-2 and rrf-1 may function in the 
same RDVI pathway. In addition, our detection that both FHV and Orsay virus replication level 
were decreased in rsd-2;drh-2 and rsd-2;ergo-1 double mutants, further confirmed both drh-2 
and ergo-1 negatively regulate rde-4-dependent RDVI pathway in C. elegans .  
3.4.1 Both FHV and Orsay Virus Replication Were Enhanced in rsd-2;rde-4 Double 
Mutants Compared to Either rsd-2 or rde-4 Single Mutants 
 
          To investigate the rsd-2-dependent genetic pathway in C. elegans, FR1gfp transgene was 
introduced to rsd-2;rde-4 double mutants through genetic crosses. After heat induction of the 
FR1gfp transgenic N2, rde-4, rsd-2, and rsd-2;rde-4 strains, the GFP expression level in the rsd-
2;rde-4 double mutants was found to be enriched compared to respective single mutants (Figure 
3.8, compare picture 4 with 2 and 3), indicating that FHV replication level in the rsd-2;rde-4 
double mutants was enhanced compared to either rsd-2 or rde-4 single mutants. 
          Total RNAs were extracted from all of the above four heat inducted strains, and northern 
blot hybridizations were performed to check FHV replication levels. We observed FHV 
replication level was enhanced in rsd-2;rde-4 double mutants (Figure 3.9A, compare the lane 4 
with 2 and 3), demonstrating a further loss of RDVI in rde-4;rsd-2 double mutants compared to 
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either rde-4 or rsd-2 single mutants. This result indicated that FHV was targeted by two parallel 
antiviral RNAi pathways in C. elegans and that rsd-2 works in an rde-4-independent antiviral 
RNAi pathway. 
 
Figure 3.8 GFP expression level was enhanced in rsd-2;rde-4 double mutants. Detection of 
green fluorescence in the FR1gfp transgenic wild type, single and double knockout worm 
mutants 48 hours post replicon replication.  
 
 
Figure 3.9 FHV and Orsay virus replication levels were enhanced in rsd-2;rde-4 double 
mutants. (A) Accumulation of the FR1gfp replicon RNAs in wild type, single and double 
knockout worm mutants 48 hours after replicon replication. (B) Accumulation of the Orsay virus 
RNA1 in wild type, single and double knockout worm mutants after growing them on Orsay 
virus particle containing food for 3 days. 
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          To further confirm our conclusion that rsd-2 works in a separate antiviral RNAi pathway 
compared to rde-4, we used Orsay virus to infect the N2, rde-4, rsd-2, and rsd-2;rde-4 mutant 
strains for 2 days, and then total RNAs were extracted for northern blot analyses. We observed 
Orsay virus replication level in rsd-2;rde-4 double mutants was enhanced (Figure 3.9B, compare 
the lane 4 with 2 and 3), further reinforcing our conclusion that rsd-2 functions in an antiviral 
RNAi pathway that does not involve rde-4. 
3.4.2 Both FHV and Orsay Virus Replication Were Enhanced in rsd-2;drh-1 Double 
Mutants Compared to Corresponding Single Mutants 
 
          If rsd-2 indeed works in a separate antiviral RNAi pathway, both FHV and Orsay virus 
replication should be enhanced in rsd-2;drh-1 double mutants because drh-1 is known to 
function downstream of rde-4 down the same genetic pathway. To test this hypothesis, FR1gfp 
transgene was introduced to rsd-2;drh-1 double mutants through genetic crosses. After heat 
inducting the FR1gfp transgenic N2, drh-1, rsd-2, and rsd-2;drh-1 strains, the GFP expression 
level was shown enhanced in rsd-2;drh-1 double mutants compared to either rsd-2 or drh-1 
single mutants (Figure 3.10, compare image 4 with 2 and 3), implying that FHV replication was 
enhanced in the rsd-2;drh-1 double mutants. 
          Total RNAs were extracted from the heat inducted strains for northern blot hybridizations 
to check FHV replication levels. The observation that FHV replication level was enhanced in 
rsd-2;drh-1 double mutants (Figure 3.11A, compare the lane 4 with 2 and 3) further upheld our 
conclusion that rsd-2 functions in an antiviral RNAi pathway that does not involve rde-4 or drh-
1.   
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Figure 3.10 Rsd-2 and drh-1 function in separate RDVI pathways. Detection of green 
fluorescence in the FR1gfp transgenic wild type, single and double knockout worm mutants 48 
hours post replicon replication. 
 
          As a reconfirmation, we used Orsay virus to infect the N2, rde-4, drh-1, and rsd-2;drh-1 
mutants for 2 days, and then total RNAs were extracted for northern blot analyses. Our 
observation that Orsay virus replication level in rsd-2;drh-1 double mutants was enhanced 
(Figure 3.11B, compare the lane 4 with 2 and 3) compared to each single mutants once again 
confirmed rsd-2 functions in a genetic pathway that does not involve rde-4 and drh-1.  
 
Figure 3.11 FHV and Orsay virus replication levels were enhanced in drh-1;rsd-2 double 
mutants. (A) Accumulation of the FR1gfp replicon RNAs in wild type, single and double 
knockout worm mutants 48 hours after replicon replication. (B) Accumulation of the Orsay virus 
RNA1 in wild type, single and double knockout worm mutants after growing them on Orsay 
virus particle containing food for 3 days. 
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3.4.3 Both FHV and Orsay Virus Replication Levels Were Enhanced in rsd-2;rde-1 Double 
Mutants Compared to Either rsd-2 or rde-1 Single Mutants 
 
          Rde-1 encodes an Argonaute protein that functions downstream of siRNA biogenesis in 
RNAi. To find out whether rsd-2 and rde-1 function in the same genetic pathway, FR1gfp 
transgene was introduced to rsd-2;rde-1 double mutants by genetic crosses. After heat induction 
of the FR1gfp transgenic N2, rde-1, rsd-2, and rsd-2;rde-1 strains, the GFP expression level was 
shown enhanced in rsd-2;rde-1 double mutants compared to either single mutants (Figure 3.12, 
compare picture 4 with picture 2 and 3), suggesting that FHV replication level was enhanced in 
the rsd-2;rde-1 double mutants. 
 
Figure 3.12 GFP expression level was enhanced in rsd-2;rde-1 double mutants. Detection of 
green fluorescence in the FR1gfp transgenic wild type, single and double knockout worm 
mutants 48 hours post replicon replication. 
 
           Northern blot hybridization also confirmed that FHV accumulated to higher levels in rsd-
2;rde-1 double mutants than those in either rde-1 or rsd-2 single mutants (Figure 3.13A, 
compare lane 4 with lane 2 and 3). Thus, we concluded rsd-2 and rde-1 function in separate 
antiviral RNAi pathways.  
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           To affirm this conclusion, Orsay virus was used to infect the N2, rsd-2, rde-1, and rsd-
2;rde-1 mutant strains for 2 days, and then total RNAs were extracted and northern blot 
hybridizations were performed to check the Orsay virus replication levels. The observations that 
the Orsay virus replication level in rsd-2;rde-1 double mutants was enhanced compared to either 
single mutants (Figure 3.13B, compare lane 4 with 2 and 3) further bolstered our conclusion that 
rsd-2 and rde-1 work in separate antiviral RNAi pathways.  
 
Figure 3.13 FHV and Orsay virus replication levels were enhanced in rsd-2;rde-1 double 
mutants. (A) Accumulation of the FR1gfp replicon RNAs in wild type, single and double 
knockout worm mutants 48 hours after replicon replication. (B) Accumulation of the Orsay virus 
RNA1 in wild type, single and double knockout worm mutants after growing them on Orsay 
virus particle containing food for 3 days. 
3.4.4 ViRNAs Accumulated in rsd-2;rde-4 Double Mutants 
          It is known that rde-4 is responsible for viRNA biogenesis in its antiviral RNAi pathway 
based on the observation of no viRNAs detected in rde-4 single mutants (Lu, Yigit et al. 2009) 
and that rsd-2 is not required for viRNA biogenesis based on the observation of viRNAs 
accumulation in rsd-2 single mutants compared to wild type strain. Thus, if it is true that rsd-2 
works in a different antiviral RNAi pathway from rde-4 and drh-1, then viRNAs would 
accumulate in rsd-2;rde-4 double mutants because mutant rde-4 should not affect the viRNA 
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biogenesis of the antiviral RNAi pathway in which rsd-2 involves and mutant rsd-2 does not 
affect the viRNA biogenesis of its own antiviral RNAi pathway since rsd-2 gene is dispensable 
for viRNA biogenesis. 
          That northern blot hybridization analysis detected viRNAs accumulated to high levels in 
rsd-2;rde-4 double mutants (Figure 3.14), further substantiated rsd-2 works in an rde-4 
independent antiviral RNAi pathway.  
 
Figure 3.14 ViRNAs accumulated in rsd-2;rde-4 double mutants. Analysis of the (-)viRNAs 
accumulation levels in the FR1gfp transgenic double knockout worm mutants 48 hours post heat 
induction. 15 µg of total small RNAs was loaded in each lane. DIG-labeled DNA oligos 
complementary to viRNA and miRNA were used as the probes. The same membrane was probed 
for miR-58 after stripping as the loading control. 
3.4.5 Neither FHV nor Orsay Virus Replication Levels in rsd-2;rrf-1 Double Mutants Were 
Enhanced Compared to Those in rsd-2 Single Mutants 
 
          To investigate the antiviral RNAi pathway that involves rsd-2, FR1gfp transgenic rsd-
2;rrf-1 double mutants were constructed through genetic crosses. Northern blot analyses showed 
that both FHV and Orsay virus replicated to similar levels in rsd-2;rrf-1 double mutants as those 
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in rsd-2 single mutants (Figure 3.15, compare lane 3 with 4), suggesting rsd-2 and rrf-1 may 
work in the same genetic pathway for antiviral RNAi.  
 
Figure 3.15 FHV and Orsay virus replication levels in rsd-2;rrf-1 double mutants were 
similar to those in rsd-2 single mutants. (A) Accumulation of the FR1gfp replicon RNAs in 
wild type, single and double knockout worm mutants 48 hours after replicon replication. (B) 
Accumulation of the Orsay virus RNA1 in wild type, single and double knockout worm mutants 
after growing them on Orsay virus particle containing food for 3 days. 
3.4.6 Both FHV and Orsay Virus Replication Levels Were Decreased in the rsd-2;drh-2 
Double Mutants Compared to Those in rsd-2 Single Mutants 
 
          To investigate the rsd-2-dependent genetic pathway for antiviral RNAi, we constructed 
FR1gfp transgenic rsd-2;drh-2 double mutants by genetic crosses. The observations that both 
FHV and Orsay virus replicated to lower levels in rsd-2;drh-2 double mutants compared to those 
in rsd-2 single mutants (Figure 3.16, compare lane 3 with 4), indicating the drh-2 mutant allele 
enhanced antiviral RNAi in the mutant rsd-2 background. This finding confirmed that the rde-4-
dependent RDVI pathway was targeted by drh-2 for negative regulation.  
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Figure 3.16 FHV and Orsay virus replication levels were decreased in rsd-2;drh-2 double 
mutants compared to those in rsd-2 single mutants. (A) Accumulation of the FR1gfp replicon 
RNAs in wild type, single and double knockout worm mutants 48 hours after replicon 
replication. (B) Accumulation of the Orsay virus RNA1 in wild type, single and double knockout 
worm mutants after growing them on Orsay virus particle containing food for 3 days. 
3.4.7 Both FHV and Orsay Virus Replication Levels Were Decreased in rsd-2;ergo-1 
Double Mutants Compared to Those in rsd-2 Single Mutants 
 
          To determine the rsd-2-denpendent genetic pathway for antiviral RNAi, we also 
constructed FR1gfp transgenic rsd-2;ergo-1 double mutants by genetic crosses. We found that 
the accumulations of both FHV and Orsay virus were decreased in rsd-2;ergo-1 double mutants 
compared to those in rsd-2 single mutants (Figure 3.17, compare lane 3 and 4), indicating that 
the ergo-1 mutant allele enhanced antiviral RNAi function in the rsd-2 mutants. This result 
confirmed that the rde-4-dependent RDVI pathway was also targeted by ergo-1 for negative 
regulation.  
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Figure 3.17 FHV and Orsay virus replication levels were decreased in rsd-2;ergo-1 double 
mutants compared to those in rsd-2 single mutants. (A) Accumulation of the FR1gfp replicon 
RNAs in wild type, single and double knockout worm mutants 48 hours after replicon 
replication. (B) Accumulation of the Orsay virus RNA1 in wild type, single and double knockout 
worm mutants after growing them on Orsay virus particle containing food for 3 days. 
3.5 Other Biological Functions of rsd-2 in C. elegans 
3.5.1 Transgene Can Be Silenced by viRNAs in the rsd-2 Mutant Strain 
          To test whether rsd-2 is required for transgene silencing mediated by viRNAs, we 
developed several FR1fp;gfp transgenic strains that contain both an FR1fp replicon transgene 
and a gfp transgene. The FR1fp replicon transgene is the same as the FR1gfp except that the 3’ 
end of the gfp sequence was used to substitute for the whole gfp sequence. GFP expression 
levels were examined 48 hours post heat induction of the transgenic N2, rsd-2, and drh-1 mutant 
strains, and we found that FR1fp replicon replicated in the rsd-2 mutant strain and GFP 
expression of this strain was suppressed accordingly (Figure 3.18). This result demonstrated that 
viRNAs produced from the FR1fp replicon were able to silence gfp transgene in the absence of 
the rsd-2 gene. We thus concluded that rsd-2 is not essential for transgene silencing mediated by 
viRNAs.  
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Figure 3.18 Rsd-2 is not important for viRNAs mediated transgene silencing. (A) FHV 
replication levels in the FR1fp;gfp transgenic worms 48 hours post heat induction. (B) GFP 
expression levels in the FR1fp;gfp transgenic worms 48 hours post heat induction. 
3.5.2 GFP Was Silenced in the FR1fp; gfp;rsd-2 Mutant Strain by Exogenous GFP dsRNA  
          To test whether rsd-2 plays a role in RNAi triggered by artificial dsRNAs, a process often 
been referred to classical RNAi, feeding RNAi strategy was used to check whether feeding the 
FR1fp;gfp;rsd-2 mutant strain with the E. coli food producing the GFP dsRNA can down-
regulate GFP expression of this strain.  
 
Figure 3.19 GFP was silenced in the rsd-2 mutant strain. (A) GFP expression levels of the 
worms fed with the regular E. coli strain. (B) GFP expression levels of the worms which were 
fed with the GFP dsRNA producing E. coli strain for 24 hours and 48 hours. 
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          After 24 and 48 hours feeding RNAi treatment, we found both green fluorescence and 
northern blot hybridization showed silencing of GFP expression in the FR1fp;gfp;rsd-2 mutant 
strain (Figure 3.19B), suggesting that rsd-2 is dispensable for artificial dsRNA triggered RNAi in 
C. elegans. This test further suggested that antiviral RNAi and classical RNAi pathways in C. 
elegans are genetically distinct although they share some genetic components such as DCR-1, 
RDE-1 and RDE-4. 
3.5.3 Rsd-2 Is Not Required for miRNA Biogenesis 
           To test whether rsd-2 is involved in miRNA mediated RNAi pathway, total small RNAs 
were extracted from the rsd-2 mutant strain and northern blot hybridization analyses were 
performed. The observation that miRNA-58 expression levels were similar between the wild 
type N2 and mutant rsd-2 strains (Figure 3.20) suggested that miRNA expression levels were not 
affected in rsd-2 mutants because miR-58 is one of the representative miRNAs of C. elegans. 
Together with our observation that the rsd-2 mutant strain did not show any development defect, 
we concluded that rsd-2 is dispensable for miRNA biogenesis or function.   
 
Figure 3.20 MiRNA-58 expression levels were not affected in rsd-2 mutants. Analysis of the 
miRNAs expression levels in wild type, single and double knockout worm mutants. 15 µg of 
total small RNAs was loaded in each lane. DIG-labeled DNA oligos complementary to miRNA 
were used as the probes. Ethidium bromide staining of tRNAs was provided to show equal 
loading. 
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CHAPTER FOUR: CONCLUSIONS 
          The observations that both Orsay and FHV viruses accumulated to high level in rsd-2 
knockout mutants and that the wild type rsd-2 gene can readily rescue the antiviral silencing in 
rsd-2 mutants confirmed rsd-2 is the gene required for antiviral silencing in C. elegans. 
          The fact that FHV replicon replicated to a much higher level in the rsd-2;rde-4 double 
mutants compared to that in corresponding single mutants indicates that rsd-2 and rde-4 work in 
separate genetic pathways for antiviral silencing in C. elegans. Consistent with this observation, 
viRNAs were detected in rde-4;rsd-2 double mutants and rsd-2 single mutants, but not in rde-4 
mutants.  
            We detected the FHV RNA1 and RNA3 accumulation and the FHV-specific viRNAs of 
the antigenomic polarity, (-)viRNAs, in rsd-2 mutants. This is in sharp contrast to the fact that no 
viRNAs were detected in rde-4 mutants. These observations ruled out a direct role of rsd-2 gene 
in virus sensing or viRNA biogenesis. Since the high-level accumulation of (-)viRNAs in rsd-2 
mutants failed to inhibit the replication level of the FHV replicon suggests that rsd-2 is essential 
for activity of viRNAs.  
          We found that the FHV replicon replicated to lower level in rsd-2;drh-2 double mutants 
compared to that in rsd-2 single mutants. This result showed that the drh-2 null allele enhanced 
antiviral silencing when rde-4-mediated antiviral silencing was functional, substantiating that the 
rde-4-initiated antiviral silencing pathway was targeted by drh-2 for negative regulation. By 
analog, we believe ergo-1 also negatively regulates the rde-4-mediated antiviral silencing.  
          Based on these findings, we conclude that rsd-2 is required for antiviral silencing in C. 
elegans, by contributing to rde-4-independent antiviral silencing. The fact that viRNAs can still 
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be detected in rsd-2 mutants suggests that rsd-2 is required for function, but not the biogenesis, 
of viRNAs. 
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CHAPTER FIVE: DISCUSSIONS 
          Prior research has demonstrated that viruses can infect and replicate in C. elegans and their 
replication can trigger RDVI (Lu, Maduro et al. 2005; Schott, Cureton et al. 2005; Wilkins, 
Dishongh et al. 2005; Liu, Lin et al. 2006). These findings suggest that C. elegans could become 
an important model for understanding basic aspects of virus–host interactions. In this work, we 
discovered that (i) the antiviral silencing induced by either FHV or Orsay virus requires rsd-2, (ii) 
the production of FHV siRNAs in the rsd-2 mutant strain is rde-4-independent, and (iii) rsd-2 is 
not essential for the sensing or biogenesis of viRNAs. These findings suggested a role of rsd-2 in 
an rde-4 independent antiviral silencing pathway. In addition, my study also demonstrated that 
rsd-2 does not play important roles in miRNA, exo-RNAi, or viRNA mediated silencing of 
cellular transcripts, suggesting a virus-specific function. 
Rsd-2 Is One of the Genetic Requirements of Antiviral RNAi in C. elegans 
          Our study confirmed that rsd-2 is one of the known RNAi factors that contribute to worm 
RDVI. The fact that the antiviral silencing against FHV and Orsay virus was further enhanced in 
both drh-2 and ergo-1 mutant worms but decreased in both rsd-2;drh-2 and rsd-2;ergo-1 double 
mutants confirmed that drh-2 and ergo-1 are negative regulators of antiviral silencing in C. 
elegans.  
C. elegans RSD-2 May Control the Target Specificity of Distinct siRNA Pathways 
        Several lines of evidence suggested that rsd-2 has a specific role in the rde-4-independent 
antiviral RNAi pathway in C. elegans. First, a further loss of the worm antiviral RNAi against 
both FHV and Orsay virus was observed in rsd-2;rde-4, rsd-2;drh-1 double mutants compared to 
either single mutants, indicating that rsd-2 and rde-4 work in separate antiviral RNAi pathways 
in C. elegans. Second, viRNAs, which are undetectable in rde-4 single mutants, became 
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detectable in rsd-2;rde-4 double mutants, suggesting that the production of viRNAs in the rsd-2 
mutant strain occurs in an rde-4-independent manner. This observation further confirmed rsd-2 
regulates a distinct siRNA pathway.  
RSD-2 Contributes to the Function of viRNAs in Worm Antiviral RNA Silencing 
           The observation that viRNAs could be detected in the rsd-2 mutants carrying the FR1gfp 
transgene suggested that rsd-2 is not essential for viRNA biogenesis in the antiviral RNAi 
pathway and that rsd-2 does not play a critical role in the sensing of the viral dsRNA triggers. 
Thus, rsd-2 could act downstream of both steps of sensing viral dsRNA triggers and processing 
viral dsRNA triggers into viRNAs. Because an RNAi factor can contribute to virus sensing, 
viRNA biogenesis or function of viRNAs, we believe that rsd-2 is required for the function of 
viRNAs. 
 Uniqueness of RSD-2 in C. elegans 
           So far, no RSD-2 homologue has been identified in other organisms, suggesting the 
uniqueness of RSD-2 mediated RDVI in C. elegans.  
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